Amgen Inc. raised its 2015 guidance after reporting that its second-quarter earnings rose 6.9% on better-than-expected sales growth and lower operating expenses. For the year, the biotechnology company now expects […]
By Tess Stynes The Wall Street Journal Biography @TessStynes [email protected] July 29, 2015 4:42 p.m. ET Vertex Pharmaceuticals Inc. said its second-quarter revenue rose 20% on strong sales of […]
Teva Pharmaceutical Industries may have found the deal it wanted in purchasing Allergan’s generics business for $40.5 billion in cash and stock, but the Israeli pharmaceutical company stands to lose around $300 […]
